Palisade Bio, Inc. (PALI)
2.00
+0.07
(+3.63%)
USD |
NASDAQ |
Apr 30, 16:00
2.02
+0.02
(+1.00%)
After-Hours: 04:49
Palisade Bio EPS Diluted (Quarterly) : -0.0558 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| ADMA Biologics, Inc. | 0.2025 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.899M |
| Total Expenses (Quarterly) | 8.899M |
| Enterprise Value | 201.93M |
| Earnings Yield | -74.24% |
| Normalized Earnings Yield | -75.75 |